Cipla Q3 net profit rises seven per cent to Rs 808 crore
Its total revenue from operations rose to Rs 5,810 crore for the third quarter compared to Rs 5,479 in the year-ago period, Cipla…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
Cipla and Ethris partner to develop mRNA-based therapies
A collaboration agreement is signed concurrently with the definitive agreement, which paves a path to market Ethris’s innovative…
Cipla’s higher automation spends to continue for three more years: CTO
The company started its investment journey on the automation front two years ago ,and has already been recognised for its work by…
US FDA designates Cipla’s Goa plant as ‘Official Action Indicated’
The US FDA may continue to withhold product approvals from this facility till the outstanding observations are resolved
Cipla beats estimates with 11 per cent rise in quarterly profit
The company has been on an acquisition spree in recent months, from buying supplement maker Endura Mass to stake purchases in…
Cipla’s Indore plant joins WEF’s Lighthouse Network
The plant demonstrates advanced technologies to drive productivity, workforce engagement, sustainability and resilience across 22…
Cipla gets US FDA nod for cancer drug
Cipla's Lenalidomide capsules are therapeutic equivalent generic version of Bristol Myers Squibb's Revlimid (Lenalidomide)…
Glenmark, Strides Pharma and Cipla recall products in US
The recall has taken place due to manufacturing issues
US FDA issues Form 483 to Cipla’s facility in MP
The FDA has censured the drug maker due to unclean equipment and lack of data
Cipla betting big on digitisation and emerging segments
The drugmaker is also bullish on maximising value opportunity in the complex generics in the US market